The antioxidant function of the p53 tumor suppressor (original) (raw)

• Lane, D.P. p53, guardian of the genome. Nature 358, 15–16 (1992).
  Article CAS Google Scholar
• Droge, W. Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47–95 (2002).
  Article CAS Google Scholar
• Finkel, T. Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15, 247–254 (2003).
  Article CAS Google Scholar
• Jackson, A.L. & Loeb, L.A. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat. Res. 477, 7–21 (2001).
  Article CAS Google Scholar
• Klungland, A. et al. Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc. Natl. Acad. Sci. USA 96, 13300–13305 (1999).
  Article CAS Google Scholar
• Beckman, K.B. & Ames, B.N. Oxidative decay of DNA. J. Biol. Chem. 272, 19633–19636 (1997).
  Article CAS Google Scholar
• Macip, S. et al. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol. Cell. Biol. 23, 8576–8585 (2003).
  Article CAS Google Scholar
• Polyak, K., Xia, Y., Zweier, J.L., Kinzler, K.W. & Vogelstein, B. A model for p53-induced apoptosis. Nature 389, 300–305 (1997).
  Article CAS Google Scholar
• Tan, M. et al. Transcriptional activation of the human glutathione peroxidase promoter by p53. J. Biol. Chem. 274, 12061–12066 (1999).
  Article CAS Google Scholar
• Hussain, S.P. et al. p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res. 64, 2350–2356 (2004).
  Article CAS Google Scholar
• Yoon, K.A., Nakamura, Y. & Arakawa, H. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J. Hum. Genet. 49, 134–140 (2004).
  Article CAS Google Scholar
• Budanov, A.V., Sablina, A.A., Feinstein, E., Koonin, E.V. & Chumakov, P.M. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304, 596–600 (2004).
  Article CAS Google Scholar
• Agarwal, M.L., Agarwal, A., Taylor, W.R. & Stark, G.R. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92, 8493–8497 (1995).
  Article CAS Google Scholar
• Ossovskaya, V.S. et al. Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc. Natl. Acad. Sci. USA 93, 10309–10314 (1996).
  Article CAS Google Scholar
• Florenes, V.A. et al. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status. J. Natl. Cancer Inst. 86, 1297–1302 (1994).
  Article CAS Google Scholar
• Velasco-Miguel, S. et al. PA26, a novel target for the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes. Oncogene 18, 127–137 (1999).
  Article CAS Google Scholar
• Lin, J., Chen, J., Elenbaas, B. & Levine, A.J. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8, 1235–1246 (1994).
  Article CAS Google Scholar
• Osovskaia, V.S. et al. Effect of on various cell lines of p53 cDNA, expressed under the control of an exogenous homologous promotor. Mol Biol (Mosk) 29, 61–70 (1995).
  CAS Google Scholar
• Kovar, H. et al. Characterization of distinct consecutive phases in non-genotoxic p53-induced apoptosis of Ewing tumor cells and the rate-limiting role of caspase 8. Oncogene 19, 4096–4107 (2000).
  Article CAS Google Scholar
• King, M.P. & Attardi, G. Injection of mitochondria into human cells leads to a rapid replacement of the endogenous mitochondrial DNA. Cell 52, 811–819 (1988).
  Article CAS Google Scholar
• Griffiths, S.D. et al. Absence of p53 permits propagation of mutant cells following genotoxic damage. Oncogene 14, 523–531 (1997).
  Article CAS Google Scholar
• Havre, P.A., Yuan, J., Hedrick, L., Cho, K.R. & Glazer, P.M. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res. 55, 4420–4424 (1995).
  CAS PubMed Google Scholar
• Bishop, A.J. et al. Atm-, p53-, and Gadd45a-deficient mice show an increased frequency of homologous recombination at different stages during development. Cancer Res. 63, 5335–5343 (2003).
  CAS PubMed Google Scholar
• Knaap, A.G. & Simons, J.W. A mutational assay system for L5178Y mouse lymphoma cells, using hypoxanthine-guanine-phosphoribosyl-transferase (HGPRT)-deficiency as marker. The occurrence of a long expression time for mutations induced by X-rays and EMS. Mutat. Res. 30, 97–110 (1975).
  Article CAS Google Scholar
• Donehower, L.A. et al. Effects of genetic background on tumorigenesis in p53-deficient mice. Mol. Carcinog. 14, 16–22 (1995).
  Article CAS Google Scholar
• Donehower, L.A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215–221 (1992).
  Article CAS Google Scholar
• Wahl, G.M., Linke, S.P., Paulson, T.G. & Huang, L.C. Maintaining genetic stability through TP53 mediated checkpoint control. Cancer Surv. 29, 183–219 (1997).
  CAS PubMed Google Scholar
• Fukasawa, K., Wiener, F., Vande Woude, G.F. & Mai, S. Genomic instability and apoptosis are frequent in p53 deficient young mice. Oncogene 15, 1295–1302 (1997).
  Article CAS Google Scholar
• Jacks, T. et al. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1–7 (1994).
  Article CAS Google Scholar
• Zurer, I. et al. The role of p53 in base excision repair following genotoxic stress. Carcinogenesis 25, 11–19 (2004).
  Article CAS Google Scholar
• Seo, Y.R. & Jung, H.J. The potential roles of p53 tumor suppressor in nucleotide excision repair (NER) and base excision repair (BER). Exp. Mol. Med. 36, 505–509 (2004).
  Article CAS Google Scholar
• Achanta, G. & Huang, P. Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents. Cancer Res. 64, 6233–6239 (2004).
  Article CAS Google Scholar
• Deng, C., Zhang, P., Harper, J.W., Elledge, S.J. & Leder, P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675–684 (1995).
  Article CAS Google Scholar
• Villunger, A. et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302, 1036–1038 (2003).
  Article CAS Google Scholar
• Jeffers, J.R. et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4, 321–328 (2003).
  Article CAS Google Scholar
• Kim, H.J. et al. Modulation of redox-sensitive transcription factors by calorie restriction during aging. Mech. Ageing Dev. 123, 1589–1595 (2002).
  Article CAS Google Scholar
• Sohal, R.S., Agarwal, S., Candas, M., Forster, M.J. & Lal, H. Effect of age and caloric restriction on DNA oxidative damage in different tissues of C57BL/6 mice. Mech. Ageing Dev. 76, 215–224 (1994).
  Article CAS Google Scholar
• Hursting, S.D., Perkins, S.N. & Phang, J.M. Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice. Proc. Natl. Acad. Sci. USA 91, 7036–7040 (1994).
  Article CAS Google Scholar
• Hursting, S.D. et al. Diet-gene interactions in p53-deficient mice: insulin-like growth factor-1 as a mechanistic target. J. Nutr. 134, 2482S–2486S (2004).
  Article CAS Google Scholar
• Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S. & Vande Woude, G.F. Abnormal centrosome amplification in the absence of p53. Science 271, 1744–1747 (1996).
  Article CAS Google Scholar
• Agapova, L.S. et al. Chromosome changes caused by alterations of p53 expression. Mutat. Res. 354, 129–138 (1996).
  Article Google Scholar
• Reliene, R., Fischer, E. & Schiestl, R.H. Effect of N-acetyl cysteine on oxidative DNA damage and the frequency of DNA deletions in atm-deficient mice. Cancer Res. 64, 5148–5153 (2004).
  Article CAS Google Scholar
• Xu, Y. et al. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10, 2411–2422 (1996).
  Article CAS Google Scholar
• Schubert, R. et al. Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice. Hum. Mol. Genet. 13, 1793–1802 (2004).
  Article CAS Google Scholar
• Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233–1238 (1990).
  Article CAS Google Scholar
• Li, F.P. et al. Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J. Natl. Cancer Inst. 84, 1156–1160 (1992).
  Article CAS Google Scholar
• Bond, G.L. et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119, 591–602 (2004).
  Article CAS Google Scholar
• Neumann, C.A. et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424, 561–565 (2003).
  Article CAS Google Scholar
• Balansky, R., Izzotti, A., Scatolini, L., D'Agostini, F. & De Flora, S. Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs. Cancer Res. 56, 1642–1647 (1996).
  CAS PubMed Google Scholar